AT Lustrum Loops – Running for Stichting Villa Joep
During the AT Lustrum Loops, we celebrate 35 years of student survival running in Eindhoven with a unique sporting challenge. On 6 and 7 June, participants will start a new 3.5-kilometre loop every hour, featuring survival running obstacles. Some participants will complete one loop, while others will take on 6 hours, 12 hours, or even the full 24-hour challenge.
But this event is about more than endurance, sportsmanship and fun. Together, we are supporting a cause close to our hearts
Stichting Villa Joep.
Villa Joep is the Dutch foundation dedicated to fighting neuroblastoma childhood cancer. Neuroblastoma is a rare and aggressive form of childhood cancer that mainly affects young children. In the Netherlands, around 25 to 30 children are diagnosed with neuroblastoma each year. Villa Joep supports scientific research into neuroblastoma, with the aim of improving the chances of recovery and ultimately helping to eliminate this disease. 100% of all donations to Villa Joep are used for research.
Create your own fundraising page
Are you taking part in the AT Lustrum Loops? Create your personal fundraising page and show everyone what you are running for. Tell people about the challenge you are taking on: will you complete one loop, 6 hours, 12 hours, or perhaps the full 24 hours?
Through your fundraising page, family, friends, colleagues, fellow students and acquaintances can sponsor you. Share your page via WhatsApp, social media, email or in person, and encourage as many people as possible to support your effort with a donation to Villa Joep.
Every loop counts
Whether you complete one loop or keep going deep into the night: every loop, every step and every donation contributes to important research into neuroblastoma. Together, we can make the AT Lustrum Loops not only an unforgettable sporting challenge, but also a meaningful fundraising event.
Create your fundraising page, share your challenge and get sponsored for Villa Joep. Together, we run for hope, research and a future for children with neuroblastoma.

